Elizabeth D Kantor

15PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersFood properties (incl. characteristics and health benefits)Nutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 11, 2026
The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancer.

Jenna Bhimani, Kelli O'Connell, Victoria S Blinder

|Feb 24, 2026
Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancer.

Maria J Monroy-Iglesias, Kelli O'Connell, Jenna Bhimani

|Dec 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer.

Yashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell

|Nov 28, 2025
Evaluation of methods to identify chemotherapy-related hematologic toxicities in real-world settings.

Peng Wang, Kelli O'Connell, Jenna Bhimani

|Aug 19, 2025
Self-Reported Adherence to Cancer Therapy: Development and Validation of the Domains of Subjective Extent of Nonadherence-Cancer Measure.

Yashasvini Sampathkumar, Corrine I Voils, Gina L Mazza

|Jun 02, 2025
Patient factors and modifications to intended chemotherapy for women with Stages I-IIIA breast cancer.

Jenna Bhimani, Peng Wang, Grace B Gallagher

Pageof 3

Frequent Collaborators

7 joint publications

Candyce H Kroenke

6 joint publications

Jenna Bhimani

6 joint publications

Erin J Aiello Bowles

6 joint publications

Isaac J Ergas